New Section 232 tariffs impose up to 100% duties on patented drugs while offering relief tied to onshoring and MFN pricing commitments.
| less than a minute read
From Zero to 100% – New Section 232 Tariffs on Patented Drugs and the High-Stakes Onshoring and MFN Choices Ahead
Get in touch
Get in touch
Get in touch
Get in touch
Latest Insights
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-08-21-17-19-26-091-6a88889ec6717a6a80e7cc6b.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-08-21-17-18-01-791-6a888849fb7086a3130aad75.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-08-21-13-50-21-233-6a88579d4b06fcfc32e1c4ce.jpg)
